S. Varini

发表

Impact of a Standardized Titration Protocol with Carvedilol in Heart Failure: Safety, Tolerability, and Efficacy—A Report from the GESICA Registry

D. Ferrante, A. Díaz, D. Nul, 2005, Cardiovascular Drugs and Therapy.

Epidemiologic, clinical, and microbiologic profile of infective endocarditis in Argentina: a national survey. The Endocarditis Infecciosa en la República Argentina-2 (EIRA-2) Study.

J. Casabé, S. Varini, E. Ferreirós, 2006, American heart journal.

N‐3 Polyunsaturated Fatty Acids to Prevent Atrial Fibrillation: Updated Systematic Review and Meta‐Analysis of Randomized Controlled Trials

D. Ferrante, G. Tognoni, J. Mariani, 2013, Journal of the American Heart Association.

DIAL trial not included in a review of health failure management programs.

D. Ferrante, H. Doval, D. Nul, 2010, Journal of the American College of Cardiology.

Hemodynamic effects of molsidomine vasodilatory therapy in acute myocardial infarction.

S. Varini, S. Caruso, A. Vasquez, 1981, American Heart Journal.

Infective Endocarditis in Argentina. Results of the EIRA 3 Study

J. Casabé, J. Gagliardi, Patricia Avellana, 2018 .

infective endocarditis in argentina . results of the eira 3 Study Endocarditis infecciosa en la República Argentina

Patricia Avellana, S. Varini, F. Nacinovich, 2022 .

Omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: results of the FORWARD (Randomized Trial to Assess Efficacy of PUFA for the Maintenance of Sinus Rhythm in Persistent Atrial Fibrillation) trial.

D. Ferrante, G. Tognoni, S. Ramos, 2013, Journal of the American College of Cardiology.

The rationale and design of the FORomegaARD Trial: A randomized, double-blind, placebo-controlled, independent study to test the efficacy of n-3 PUFA for the maintenance of normal sinus rhythm in patients with previous atrial fibrillation.

D. Ferrante, G. Tognoni, H. Doval, 2009, American heart journal.

Nonsustained ventricular tachycardia in severe heart failure. Independent marker of increased mortality due to sudden death. GESICA-GEMA Investigators.

S. Dubner, H. Doval, D. Nul, 1996, Circulation.

Long-term results after a telephone intervention in chronic heart failure: DIAL (Randomized Trial of Phone Intervention in Chronic Heart Failure) follow-up.

D. Ferrante, H. Doval, D. Nul, 2010, Journal of the American College of Cardiology.

Randomized Trial of Telephone Intervention in Chronic Heart Failure (DIAL): study design and preliminary observations.

D. Ferrante, Daniel Ferrante, H. Doval, 2003, Journal of cardiac failure.

Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF

G. Breithardt, H. Crijns, P. Mclaughlin, 2016, Journal of the American Heart Association.

Seasonal variation and trends in heart failure morbidity and mortality in a South American community hospital.

D. Ferrante, A. Díaz, H. Doval, 2007, Congestive heart failure.

Omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: results of the FORWARD (Randomized Trial to Assess Efficacy of PUFA for the Maintenance of Sinus Rhythm in Persistent Atrial Fibrillation) trial.

D. Ferrante, G. Tognoni, S. Ramos, 2013, Journal of the American College of Cardiology.

Reply: To PMID 23265344.

J. Mariani, H. Grancelli, H. Doval, 2013, Journal of the American College of Cardiology.